🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share that our work Smidt Heart Institute at Cedars-Sinai on ischemia-reperfusion injury post-heart transplant, as well as our study on heart-kidney transplant patients bridged with D-MCS, has been selected for 3 moderated presentations at the American Heart Association Scientific Sessions

GBD data highlights Pulmonary Arterial Hypertension (PAH)'s substantial burden worldwide, affecting women at a higher rate than men. In 2021, there was an estimated 192K cases globally, women accounting for 62% (119K) of cases with men making up the rest →ms.spr.ly/6010W6pOK

I am excited to present this weekend at the American Heart Association Scientific Sessions 2024 #AHA24! in Chicago! Celebrating 100 years of Cardiology science and hope! AHAMeetings AHA Science Smidt Heart Institute at Cedars-Sinai

Great #AHA2024 presentation from Cedars-Sinai Cardiology Fellowship Dr. Rashmi Jain: Highly sensitized patients treated with desensitization prior to HT had higher rates of AMR but comparable survival and CAV rates compared to general HT population. Smidt Heart Institute at Cedars-Sinai The ISHLT Michelle Kittleson MD PhD Lily K Stern MD

Presenting our findings on predictors of Ischemia reperfusion injury post heart transplant #AHA24 Smidt Heart Institute at Cedars-Sinai Cedars-Sinai Academic Medicine We found that: Optimal prioritization of HTx candidates on the waitlist and use of ATG induction therapy seem to protect against immediate ischemia

So happy to reconnect with You, Obada! Keep up the great work!

One of my unintended passions is now exploring: How do we make #cardioonc succeed, 1 program at a time? @yosefmanla Diego Sadler MD FACC et al reveal building blocks needed to build a program & how to leverage your local strengths & gaps in care for success! link.springer.com/article/10.100… 8/🧵

I am excited to share our recent publication JHLT, demonstrating how therapeutic plasma exchange improves survival in patients experiencing severe primary graft dysfunction after heart transplantation. Link: doi.org/10.1016/j.heal… Beyond grateful to my mentor,

Excited to share that our paper “Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic Sclerosis” is now on JACC Journals🫀🔬. Thank you Eduardo Marban, MD, PhD for the mentorship and ongoing support. Smidt Heart Institute at Cedars-Sinai Yale Internal Medicine jacc.org/doi/10.1016/j.…

New online! 🗒️Pleased to share that our State-of-the-Art Review on SSc associated cardiovascular disease is now published on JSRD. Thank you Eduardo Marban, MD, PhD for the constant support. @scleroderma Smidt Heart Institute at Cedars-Sinai Yale Internal Medicine journals.sagepub.com/eprint/DXQC2VW…

Presenting our case series on variable responses to daratumumab for pre-transplant desensitization in adult heart transplant candidates #ISHLT2025 The ISHLT Smidt Heart Institute at Cedars-Sinai #transplantimmunology

Does Time Matter in #PGD presentation? The ISHLT Yosef Manla, MD, FESC ➡️ Study shows worse outcomes in immediate vs. delayed presentation w/ ⬇️ survival at 30d & 1 yr

Presented this at #ISHLT2025: In our single-center study Smidt Heart Institute at Cedars-Sinai , pre- heart transplant sensitization & older donor age were associated with immediate presentation of severe PGD-LV ⚠️. Immediate presentation = worse 30-day & 1-yr survival vs delayed presentation 📉.The ISHLT

Don't let great research stall. With JCF Express: Court of Appeals you can submit your previously reviewed manuscript for an expedited editorial decision. No starting over. No wasted effort. Resubmit today hfsa.org/jcf-express-co…